rs143207434
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001164688.2(RD3):c.584A>T(p.Asp195Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,596,836 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001164688.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RD3 | NM_001164688.2 | c.584A>T | p.Asp195Val | missense_variant | 3/3 | ENST00000680073.1 | NP_001158160.1 | |
RD3 | NM_183059.3 | c.584A>T | p.Asp195Val | missense_variant | 3/3 | NP_898882.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RD3 | ENST00000680073.1 | c.584A>T | p.Asp195Val | missense_variant | 3/3 | NM_001164688.2 | ENSP00000505312 | P1 | ||
RD3 | ENST00000367002.5 | c.584A>T | p.Asp195Val | missense_variant | 3/3 | 1 | ENSP00000355969 | P1 | ||
RD3 | ENST00000484910.1 | n.552A>T | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1590AN: 152198Hom.: 15 Cov.: 33
GnomAD3 exomes AF: 0.00889 AC: 2097AN: 235966Hom.: 19 AF XY: 0.00875 AC XY: 1130AN XY: 129104
GnomAD4 exome AF: 0.0101 AC: 14584AN: 1444520Hom.: 101 Cov.: 33 AF XY: 0.0100 AC XY: 7175AN XY: 717160
GnomAD4 genome AF: 0.0104 AC: 1589AN: 152316Hom.: 15 Cov.: 33 AF XY: 0.0112 AC XY: 835AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 14, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 10, 2021 | - - |
Leber congenital amaurosis 12 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 19, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at